Management of infective endocarditis: challenges and perspectives

F Thuny, D Grisoli, F Collart, G Habib, D Raoult - The Lancet, 2012 - thelancet.com
Despite improvements in medical and surgical therapies, infective endocarditis is associated
with poor prognosis and remains a therapeutic challenge. Many factors affect the outcome of …

A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses

WJ Munckhof, ML Grayson… - Journal of Antimicrobial …, 1996 - academic.oup.com
We performed a meta-analysis of randomised clinical studies in which the efficacy and
toxicity of the same total daily dose of aminoglycosides administered once-daily was …

Phage-antibiotic combination is a superior treatment against Acinetobacter baumannii in a preclinical study

FLG Altamirano, X Kostoulias, D Subedi, D Korneev… - …, 2022 - thelancet.com
Background Clinical phage therapy is often delivered alongside antibiotics. However, the
phenomenon of phage-antibiotic synergy has been mostly studied in vitro. Here, we …

Synergy between conventional antibiotics and anti-biofilm peptides in a murine, sub-cutaneous abscess model caused by recalcitrant ESKAPE pathogens

D Pletzer, SC Mansour, REW Hancock - PLoS pathogens, 2018 - journals.plos.org
With the antibiotic development pipeline running dry, many fear that we might soon run out
of treatment options. High-density infections are particularly difficult to treat due to their …

Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms

WR Wilson, AW Karchmer, AS Dajani, KA Taubert… - Jama, 1995 - jamanetwork.com
Objective.—To provide guidelines for the treatment of endocarditis in adults caused by the
following microorganisms: viridans streptococci and other streptococci, enterococci …

The population dynamics of antimicrobial chemotherapy

M Lipsitch, BR Levin - Antimicrobial agents and chemotherapy, 1997 - Am Soc Microbiol
We present and analyze a series of mathematical models for the emergence of resistance
during antibiotic treatment of an infected host. The models consider the population dynamics …

In vitro and in vivo interactions between miltefosine and other antileishmanial drugs

K Seifert, SL Croft - Antimicrobial agents and chemotherapy, 2006 - Am Soc Microbiol
The interaction of miltefosine with amphotericin B, sodium stibogluconate, paromomycin,
and sitamaquine was assessed in vitro and additionally for the first three combinations in …

Evaluation of antimicrobial regimens for treatment of experimental penicillin-and cephalosporin-resistant pneumococcal meningitis

IR Friedland, M Paris, S Ehrett, S Hickey… - Antimicrobial agents …, 1993 - Am Soc Microbiol
The most appropriate therapy for meningitis caused by Streptococcus pneumoniae strains
resistant to the extended-spectrum cephalosporins is unknown. We evaluated ceftriaxone …

Tests for bactericidal effects of antimicrobial agents: technical performance and clinical relevance

LR Peterson, CJ Shanholtzer - Clinical microbiology reviews, 1992 - Am Soc Microbiol
Bactericidal testing has been used for several decades as a guide for antimicrobial therapy
of serious infections. Such testing is most frequently performed when bactericidal …

Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci

JF Boyle, SA Soumakis, A Rendo… - Journal of Clinical …, 1993 - Am Soc Microbiol
We are reporting on a nosocomial outbreak of 213 cases of vancomycin-resistant
enterococcus infection involving 2,812 enterococcal isolates from patients over a period of …